Pacific Biosciences amends 2020 Equity Incentive Plan effective June 3, 2026
Pacific Biosciences filed an amended and restated 2020 Equity Incentive Plan with updates effective June 3, 2026, covering stock options, RSUs, and performance-based awards for employees, directors and consultants. The amendment reflects routine plan governance changes to maintai
View filing at SEC.gov →